Results 91 to 100 of about 3,678 (166)

Polymorphism engineering of mefenamic acid for enhanced pharmacokinetic performance. [PDF]

EXCLI J
Prasher P, Sharma M.
europepmc   +1 more source

Comparison of effect of auriculotherapy and mefenamic acid on the severity and systemic symptoms of primary dysmenorrhea: a randomized clinical trial. [PDF]

Trials, 2021
Vahedi M, Hasanpoor-Azghady SB, Amiri-Farahani L, Khaki I.   +3 more
europepmc   +1 more source

Solubility enhancement of mefenamic acid by inclusion complex with β-cyclodextrin: in silico modelling, formulation, characterisation, and in vitro studies. [PDF]

J Enzyme Inhib Med Chem, 2021
Sid D, Baitiche M, Elbahri Z, Djerboua F, Boutahala M, Bouaziz Z, Le Borgne M.   +6 more
europepmc   +1 more source

Mefenamic Acid Poisoning Revisited: Central Nervous System Toxicity and Acute Kidney Injury. [PDF]

Cureus
Inoue F, Okazaki Y, Ichiba T, Namera A.
europepmc   +1 more source

Mefenamic acid.

Indian pediatrics, 1990
G R, Singh, P, Choudhury
openaire   +3 more sources

A novel nail polish/graphite/nickel nanoparticles-based disposable screen-printed sensor for enhanced voltammetric detection of mefenamic acid in environmental water samples. [PDF]

Mikrochim Acta
Teixeira LEDC, Silva FWL, Macedo AA, de Souza OPL, Ferreira JHA, Canevari TC, Santelli RE, de Faria LV, Cincotto FH.   +8 more
europepmc   +1 more source

Physiologically-Based Pharmacokinetic Modeling of the Drug-Drug Interaction of the UGT Substrate Ertugliflozin Following Co-Administration with the UGT Inhibitor Mefenamic Acid. [PDF]

CPT Pharmacometrics Syst Pharmacol, 2021
Callegari E, Lin J, Tse S, Goosen TC, Sahasrabudhe V.   +4 more
europepmc   +1 more source

Effectiveness and Safety of Mefenamic Acid Oral Suspension in Pediatric Practice for Febrile Illness: An Observational Study (EASE-O-MAPP Study). [PDF]

Cureus
Khalatkar V, Kasture PN, Kumar D.
europepmc   +1 more source

Consensus on the Use of Mefenamic Acid in Pediatric Practice (MAPP): Perspectives From Indian Pediatricians. [PDF]

Cureus
Pai U, Venkata RA, Shah A, Gupta A, Clement A, Wadhwa A, Kumar A, Somasundaram A, Charde G, Joshi KK, Sanklecha M, Suresh Kumar MV, Gokhale P, Agarwal R, Shah R, Chhabra R, Niranjan S, Dudhgaonkar S, Surampudi S, Nayak S, Borkar VV.   +20 more
europepmc   +1 more source

Monitoring Apoptotic Activity of Silver(I) Metallodrugs Containing Mefenamic Acid and Mitochondriotropic Agents in Artificial Breast Tumor Tissues. [PDF]

ChemMedChem
Banti CN, Hadjikakou SK.
europepmc   +1 more source